Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 8/2020

01-08-2020 | Colon Cancer | Original Article – Clinical Oncology

Harvest of at least 18 lymph nodes is associated with improved survival in patients with pN0 colon cancer: a retrospective cohort study

Authors: Fei-Long Ning, Jun-Peng Pei, Nan-Nan Zhang, Jun Wang, Hong-Guang Quan, Zu-Bing Mei, Xian-Tao Zeng, Masanobu Abe, Chun-Dong Zhang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 8/2020

Login to get access

Abstract

Purpose

To investigate the correlation between number of retrieved lymph nodes (rLNs) and prognosis and further ascertain the optimal number of rLNs with a beneficial survival impact in patients with pN0 colon cancer.

Methods

The Surveillance, Epidemiology, and End Results (SEER) database was searched for pN0 colon cancer cases. X-Tile software and Kaplan–Meier survival analysis were applied to determine the optimal number of rLNs based on the minimal probability (P) value and the largest χ2 value. Univariate analyses and Cox proportional hazard regression model were used to investigate the relationship between rLN number and overall survival. Multiple analyses were conducted to assess the prognostic predictive ability of the identified optimal rLN cut-off value under different stratifications. Nomograms were established based on the independent prognostic factors selected by the multivariate analysis to predict 3- and 5-year overall survival rates of pN0 patients.

Results

A total of 6269 pN0 colon cancer patients who underwent surgical therapy were finally included for analysis. Harvest of at least 18 lymph nodes was determined as the optimal rLN number. This cut-off rLN value (< 18 versus ≥ 18) was identified as an independent prognostic factor (P < 0.001) of overall survival via multivariate analysis. Similar findings were obtained in patients with retrieval of at least 12 lymph nodes (18 > rLNs ≥ 12 versus rLNs ≥ 18) stratified into several groups.

Conclusions

The number of rLNs was identified as an independent prognostic factor for pN0 colon cancer. Retrieval of at least 18 lymph nodes was associated with favorable prognosis in patients with pN0 colon cancer, and should, therefore, be regarded as an alternative cut-off value for survival analysis.
Appendix
Available only for authorised users
Literature
go back to reference Amin MB, Edge SB (2017) AJCC cancer staging manual, 8th edn. Springer, New YorkCrossRef Amin MB, Edge SB (2017) AJCC cancer staging manual, 8th edn. Springer, New YorkCrossRef
go back to reference Brierley JD, Gospodarowicz MK, Wittekind C (2017) The TNM classification of malignant tumours, 8th edn. Wiley Blackwell, Oxford Brierley JD, Gospodarowicz MK, Wittekind C (2017) The TNM classification of malignant tumours, 8th edn. Wiley Blackwell, Oxford
go back to reference National Cancer Institute (2018) Surveillance, epidemiology, and end results (SEER) program, research data (1973–2015). National Cancer Institute: Bethesda, MD, USA. www.seer.cancer.gov. Accessed 19 Feb 2019 National Cancer Institute (2018) Surveillance, epidemiology, and end results (SEER) program, research data (1973–2015). National Cancer Institute: Bethesda, MD, USA. www.​seer.​cancer.​gov. Accessed 19 Feb 2019
Metadata
Title
Harvest of at least 18 lymph nodes is associated with improved survival in patients with pN0 colon cancer: a retrospective cohort study
Authors
Fei-Long Ning
Jun-Peng Pei
Nan-Nan Zhang
Jun Wang
Hong-Guang Quan
Zu-Bing Mei
Xian-Tao Zeng
Masanobu Abe
Chun-Dong Zhang
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 8/2020
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-020-03212-y

Other articles of this Issue 8/2020

Journal of Cancer Research and Clinical Oncology 8/2020 Go to the issue

Original Article – Cancer Research

Expression of H3K4me3 and H3K9ac in breast cancer

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.